DMT-Focused Psychedelic Company Small Pharma Launches on TSX Venture Exchange
DMT-focused psychedelic therapy company Small Pharma is listing on the Canadian TSK Venture Exchange as it ramps up its offerings.
dmt
Psychedelic Business News Spotlight: May 7, 2021
This week in psychedelic business news: LSD for pain, DMT and organ transplants, Champignon Brands is now Braxia Scientific Corp, and more.
GH Research Raises $125 Million to Fund DMT Treatment for Depression
GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment.
Small Pharma Clinical Trials to Study DMT for Treatment-Resistant Depression
Small Pharma is going into clinical trials to look at DMT for depression relief. The UK company says it believes benefits will be immediate.
Algernon to Investigate DMT Microdose for Stroke Treatment
Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.
Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
End of content
End of content